drugset / Trial / NCT02320708
Study of Acetaminophen (ACE) in Post-operative Dental Pain
Phase 2
Completed
240 enrolled
Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc.
Johnson & Johnson Consumer and Personal Products Worldwide · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a dental pain study evaluating the efficacy and safety of a single dose of test acetaminophen (ACE) (1000 mg) compared to commercial acetaminophen (1000 mg), ibuprofen (IBU) (400 mg), and placebo over a 6 hour period. Subjects will undergo dental extraction of three or four third molars.
Timeline
- Start
- 2014-12-31
- Primary completion
- 2015-04-30
- Completion
- 2015-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acetaminophen | Small molecule | 1000 mg | Oral |
| Comparator | Ibuprofen | Small molecule | 400 mg | Oral |
Indications
No indication recorded.